WMS Partners’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,600
Closed -$202K 221
2018
Q2
$202K Buy
+1,600
New +$195K 0.02% 215
2016
Q3
Sell
-1,900
Closed -$235K 192
2016
Q2
$235K Buy
+1,900
New +$229K 0.03% 185
2015
Q3
Sell
-1,900
Closed -$217K 212
2015
Q2
$217K Buy
+1,900
New +$230K 0.03% 252
2014
Q4
Sell
-1,900
Closed -$278K 220
2014
Q3
$278K Buy
+1,900
New +$293K 0.04% 202

Other funds holding CLB

WMS Partners's CLB Position: Q3 2018 in Review

WMS Partners sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 1,600 shares — an estimated $202K sold.

WMS Partners first reported a position in CLB in Q3 2014 and held it in 4 quarters. The position peaked at $278K in Q3 2014. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

  • WMS Partners reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
  • WMS Partners sold 1,600 Core Laboratories shares in Q3 2018, an estimated $202K.
  • WMS Partners first reported a position in Core Laboratories in Q3 2014 and held it in 4 quarters.
  • WMS Partners's Core Laboratories position peaked at $278K in Q3 2014.
  • 359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on WMS Partners's 13F filing for Q3 2018, filed 8 Nov 2018.